Efficacy of the Comprehensive Headache Clinic at the Bangkok Hospital: The First 6 Months’ Report

Article Sidebar

PDF
Published: Feb 20, 2013
DOI: https://doi.org/10.31524/bkkmedj.2013.02.005
Keywords:
headache clinic, primary headache, secondary headache, migraine, HIT-6, Bangkok hospital

Main Article Content

Nucharin Jindawong, BN, MBA
Kiratikorn Vongvaivanich, MD

Abstract

OBJECTIVE: To study the effi cacy of the Comprehensive Headache Clinic.


MATERIALS AND METHODS: There were 302 patients who presented at the Headache clinic between July 2011 and January 2012. The effi cacy of treatment was evaluated with questionnaires including Headache Impact TestTM (HIT-6TM), Pain Score, and Headache frequency per week.


RESULTS: Of the 302 cases, 113 (37.42%) completed a four-week followup. The effi cacy of treatment was analysed by using Paired T-test. The impact of headache symptoms, the severity, and the frequency of headache per week had decreased signifi cantly from a statistical point of view. HIT-6TM Score day 0 = 62±5.66, day 28 = 52±7.15 (p < 0.01, t = 2.13), Pain Score day 0 = 7±1.92, day 28 = 3±2.46 (p < 0.01, t = 1.96), Headache frequency per week day 0 = 3±2.68, day 28 = 1±1.87 (p < 0.01, t = 2.58).


CONCLUSION: Findings from the Comprehensive Headache Clinic signifi cantly demonstrate effi cacy in reducing severity, frequency, and the impact of headache symptoms on patients’ daily lives.

Article Details

How to Cite
1.
Jindawong N, Vongvaivanich K. Efficacy of the Comprehensive Headache Clinic at the Bangkok Hospital: The First 6 Months’ Report. BKK Med J [Internet]. 2013 Feb. 20 [cited 2024 Nov. 22];5:25. Available from: https://he02.tci-thaijo.org/index.php/bkkmedj/article/view/218053
Issue
Vol. 5 (2013): February
Section
Original Article

This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

References

1. Silberstein SD, LiPton RB, Dodick DW, et al. Wolff ’s Headache and Other Head Pain. United States of America: Oxford University Press, Inc. 2008.
2. Matchar DB, Harpole L, Samsa GP, et al. The Headache Management Trial: A Randomized Study of Coordinated Care. Headache 2008;48:1294-310.
3. Stewart WF, Lipton RB, Kolodner KB, et al. Reliability of the migraine disability assessment score in a population- based sample of headache sufferers. Cephalalgia 1999; 19:107-14.
4. Headache Classification Committee of the International Headache Society. The international classification of headache disorders, 2nd edition. Cephalalgia 2004; 24:1-160.
5. Silberstein SD. Practice parameter: Evidence-based guidelines for migraine headache (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2000;55:754-62.
6. Holland S, Silberstein SD, Freitag F, et al. Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society. Evidence-based guideline update: NSAIDs and other complementary treatments for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology 2012;78:1346-53.
7. Loder E, Burch R, Rizzoli P. The 2012 AHS/AAN guide- lines for prevention of episodic migraine: a summary and comparison with other recent clinical practice guidelines. Headache 2012;52:930-45.
8. Evers S, Afra J, Frese A, et al. European Federation of Neurological Societies. EFNS guideline on the drugtreatment of migraine-revised report of an EFNS taskforce. Eur J Neurol 2009;16:968-81.
9. Bendtsen L, Evers S, Linde M, et al. EFNS guideline on the treatment of tension-type headache –Report of an EFNS task force. Eur J Neurol 2010;17:1318-25.
10. Francis GJ, Becker WJ, Tamara M. Pringsheim. Acute and preventive pharmacologic treatment of cluster headache. Neurology 2010;75:463-73.
11. Ashkenazi A, Blumenfeld A, Napchan U, et al. Interven- tional Procedures Special Interest Section of the American. Peripheral Nerve Blocks and Trigger Point Injections in Headache Management-A Systematic Review and Suggestions for Future Research. Headache 2010;50:943-52.
12. Tobin J, Flitman S. Occipital nerve blocks: when and what to inject? Headache 2009;49:1521-33.
13. Blumenfeld A, Silberstein SD, Dodick DW, et al. Method of injection of onabotulinumtoxinA for chronic migraine: a safe, well-tolerated, and effective treatment paradigm based on the PREEMPT clinical program. Headache 2010;50:1406-18.
14. Nicholson RA, Buse DC, Andrasik F, et al. Nonpharmaco- logic treatments for migraine and tension-type headache: how to choose and when to use. Curr Treat Options Neurol 2011;13:28-40.
15. Kosinki M, Bayliss MS, Bjorner JB, et al. A six item short form survey for measuring headache impact: the HIT-6. Qual Life Res 2003;12:963-74.
16. Andrasik F.Biofeedback in headache:an overview of approaches and evidence.Cleve Clin J Med 2010;77:S72-6.
17. The study of pain association in Thailand: The Develop- ment of Acute Pain. Edition 1, Bangkok.
18. Sauro KM, Becker WJ. Multidisciplinary treatment for headache in the Canadian healthcare setting. Can J Neurol Sci 2008;35:46-56.